Commission to a 1099 medical sales rep on federal-program business is a known anti-kickback risk. Here is what the personal services safe harbor requires, and why hourly is the cleaner structure.
Managing a 1099 Medical Sales Contractor Versus a W2 Rep: What Actually Changes
A look at the math on testing new geographic territories with contract reps before committing to W2 hires at Series A.
Commission-based 1099 medical sales reps and AKS risk in 2025. What 42 U.S.C. § 1320a-7b(b) and 42 C.F.R. § 1001.952(d) require, what Sorensen and Marchetti changed, and what legal teams should document.
Outsourced medical device sales options compared with real cost, deployment speed, management load, and compliance structure considerations for CSO, 1099 marketplace, and hybrid models.
In-house W2 reps, traditional CSOs, or a contractor marketplace: what each model actually costs, what nobody publishes upfront, and which makes sense for your situation.
